I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Pulsoni, A.
339
results:
Format
Online (338)
Print (1)
Mediatypes
Books (1)
Articles (Online) (152)
OpenAccess-fulltext (185)
Thesis (Online) (1)
Languages
english (267)
german (9)
more...
italian (15)
portuguese (3)
spanish (3)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Early clearance of hairy cell leukaemia in the bone marrow ..:
Ligia, S.
;
Passucci, M.
;
Assanto, G. M.
...
British Journal of Haematology. 204 (2023) 4 - p. 1288-1292 , 2023
Link:
https://doi.org/10.1111/..
?
2
COMBINED USE OF MINIMAL RESIDUAL DISEASE MONITORING AND FDG..:
Ferrero, S.
;
Assanto, G. M.
;
Durmo, R.
...
Hematological Oncology. 41 (2023) S2 - p. 183-185 , 2023
Link:
https://doi.org/10.1002/..
?
3
The impact of spleen metabolic tumor volume on total metabo..:
Guerra, L.
;
Chauvie, S.
;
Marcheselli, L.
...
Hematological Oncology. 41 (2023) S2 - p. 339-340 , 2023
Link:
https://doi.org/10.1002/..
?
4
MARGINAL ZONE LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (MZL‐..:
Luminari, S.
;
Bommier, C.
;
Fabbri, N.
...
Hematological Oncology. 41 (2023) S2 - p. 102-103 , 2023
Link:
https://doi.org/10.1002/..
?
5
FRONTLINE INTENSIFIED ABVD DEMONSTRATES SUPERIOR EFFICACY T..:
Pinto, A.
;
Corazzelli, G.
;
Evangelista, A.
...
Hematological Oncology. 41 (2023) S2 - p. 31-33 , 2023
Link:
https://doi.org/10.1002/..
?
6
THE IELSG39 TRIAL: EFFICACY OF FIRST‐LINE CHLAMYDIA PSITTAC..:
Ferreri, A. J. M.
;
Sassone, M. C.
;
Cangi, M. G.
...
Hematological Oncology. 41 (2023) S2 - p. 106-107 , 2023
Link:
https://doi.org/10.1002/..
?
7
Prognostic value of the end of induction PET in patients wi..:
Guerra, L.
;
Bergesio, F.
;
Fallanca, F.
...
Hematological Oncology. 41 (2023) S2 - p. 378-378 , 2023
Link:
https://doi.org/10.1002/..
?
8
UPDATED RESULTS OF THE FIL "MIRO" STUDY, A MULTICENTER PHAS..:
Pulsoni, A.
;
Tosti, M. E.
;
Ferrero, S.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
9
RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPH..:
Luminari, S.
;
Galimberti, S.
;
Versari, A.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
10
PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A..:
Pirosa, M. C.
;
Orsucci, L.
;
Feugier, P.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
11
DIRECT‐ACTING ANTIVIRALS AS PRIMARY TREATMENT FOR HCV‐ASSOC..:
Merli, M.
;
Rattotti, S.
;
Spina, M.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
12
EARLY METABOLIC RESPONSE IN FOLLICULAR LYMPHOMA: A SUBSET A..:
Luminari, S.
;
Guerra, L.
;
Durmo, R.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
13
FAVOURABLE PROGNOSTIC ROLE OF HIGH BASAL MAXIMAL STANDARDIZ..:
Assanto, G. M.
;
Ciotti, G.
;
Brescini, M.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
14
THE ROLE OF END OF TREATMENT PET CT EVALUATED BY DEAUVILLE ..:
Assanto, G. M.
;
Agrippino, R.
;
Lapietra, G.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
15
BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CEL..:
Massaro, F.
;
Pavone, V.
;
Stefani, P. M.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
1-15